Regulation of mucosal immunity in the female reproductive tract: The role of sex hormones in immune protection against sexually transmitted pathogens

American Journal of Reproductive Immunology

Volumn 72, Issue 2, 2014, Pages 236-258

  Wira, Charles R ^a   Fahey, John V ^a   Rodriguez Garcia, Marta ^a   Shen, Zheng ^a   Patel, Mickey V ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Epithelial cells; Female reproductive tract; Fibroblasts; Immune cells; Mucosal immunity; Sex hormones

Indexed keywords

ANTIBODY; ANTIINFECTIVE AGENT; CHEMOKINE; CHEMOKINE RECEPTOR; SEX HORMONE; ESTRADIOL; PROGESTERONE;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL MIGRATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPITHELIUM CELL; FEMALE GENITAL SYSTEM; FERTILIZATION; FIBROBLAST; HORMONAL REGULATION; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MENSTRUAL CYCLE; MONOCYTE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERUS; VAGINA; FEMALE; HIV INFECTIONS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; MUCOSA; PATHOLOGY; VIROLOGY;

EPITHELIAL CELLS; ESTRADIOL; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; LYMPHOCYTES; MACROPHAGES; MENSTRUAL CYCLE; MUCOUS MEMBRANE; PREGNANCY; PROGESTERONE;

EID: 84904348035     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12252     Document Type: Review

References (145)

1. UNAIDS: UNAIDS 2008. AIDS Epidemic Update, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). Geneva, Switzerland, 2008.
2. UNAIDS: AIDS Epidemic Update JUNPoHAUaWHOW. Geneva, Switzerland, 2007.
3. Ogra P, Yamanaka T, Losonsky GA: Local immunologic defenses in the genital tract. In Reproductive Immunology, N Fleicher (ed). New York, Alan R. Liss, Inc., 1981, pp 381-394.
4. Wira CR, Fahey JV, White HD, Yeaman GR, Given AL, Howell AL: The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In The Endometrium, S Glasser, J Aplin, L Guidice, S Tabibzadeh (eds). New York, Taylor and Francis, 2002, pp 371-404.
5. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.
6. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L: Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:306-335.
7. Wira CR, Grant-Tschudy KS, Crane-Godreau M: Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol 2005; 53:1-12.
8. Fahey JV, Schaefer TM, Channon JY, Wira CR: Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 2005; 20:1439-1446.
9. Fahey JV, Schaefer TM, Wira CR: Sex hormone modulation of human uterine epithelial cell immune responses. Integr Comp Biol 2006; 46:1082-1087.
10. Kaushic C, Wira CR: IgA and reproductive tract immunity. In Mucosal Immune Defense: Immunoglobulin A. C Kaetzel (ed). New York, Kluwer Academic/Plenum Publisher, 2008, pp 291-320.
11. Wira CR, Fahey JV: The innate immune system: gatekeeper to the female reproductive tract. Immunology 2004; 111:13-15.
12. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, Rossoll RM, Wira CR: Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal Immunol 2008; 1:317-325.
13. Dahlenbach-Hellweg G: Histopathology of the Endometrium, 2nd edn. New York, Springer-Verlag, 1975.
14. Morris H, Edwards J, Tiltman A, Emms M: Endometrial lymphoid tissue: an immunohistological study. J Clin Pathol 1985; 38:644-652.
15. Bulmer JN, Earl U: The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle. Immunology 1987; 61:207-213.
16. Hunt JS: Immunologically relevant cells in the uterus. Biol Reprod 1994; 50:461-466.
17. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, Wira CR: Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997; 38:350-359.
18. Mselle TF, Meadows SK, Eriksson M, Smith JM, Shen L, Wira CR, Sentman CL: Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol 2007; 124:69-76.
19. Smith JM, Wira CR, Fanger MW, Shen L: Human fallopian tube neutrophils: a distinct phenotype from blood neutrophils. Am J Reprod Immunol 2006; 56:218-229.
20. Piguet V, Steinman RM: The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 2007; 28:503-510.
21. Yeaman GR, Fazleabas AT, Wira CR: Endometrial lymphoid aggregates. Mucosal Immunol Update 2004; 12:6-8.
22. Yeaman GR, Collins JE, Fanger MW, Wira CR, Lydyard PL: T cell receptor Vb usage in human uterine endometrial lymphoid aggregates shows no clonal restriction: evidence that uterine lymphoid aggregates arise by cell trafficking. Immunology 2001; 102:434-440.
23. White HD, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, Green WR, Wira CR: CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158:3017-3027.
24. White HD, Crassi K, Wira CR: Cytolytic functional activities of NK cells and cytotoxic T lymphocytes (CTL) are coordinately regulated in the human female reproductive tract. In Mucosal Solutions: Advances in Mucosal Immunology. AJ Husband, KW Beagley, RL Clancey, AM Collins, AW Cripps, DL Emery (eds). Sydney, Australia, The University of Sydney, 1997, pp 385-391.
25. Dominguez F, Galan A, Martin JJL, Remohi J, Pellicer A, Simón C: Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. Mol Hum Reprod 2003; 9:189-198.
26. Jones RL, Hannan NJ, Kaitu'u TJ, Zhang J, Salamonsen LA: Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004; 89:6155-6167.
27. Yeaman GR, Howell AL, Weldon S, Damien DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW: HIV receptor and coreceptor expression on human uterine epithelial cells during the menstrual cycle. Immunology 2003; 109:137-146.
28. Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Wira CR, Fanger MW, Howell AL: Chemokine receptor expression in the human cervix: implications for infection by the human immunodeficiency virus-type I (HIV-1). Immunology 2004; 113:524-533.
29. Sullivan DA, Richardson GS, MacLaughlin DT, Wira CR: Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J Steroid Biochem 1984; 20:509-513.
30. Tauber PF, Wettich W, Nohlen M, Zaneveld LJ: Diffusible proteins of the mucosa of the human cervix, uterus, and fallopian tubes: distribution and variations during the menstrual cycle. Am J Obstet Gynecol 1985; 15:1115-1125.
31. Schumacher GFB: Soluble proteins in cervical mucus. In The Biology of the Cervix. RJ Blandau, K Moghissi (eds). Chicago, The University of Chicago Press, 1973, pp 201-233.
32. Kutteh KW, Moldoveanu Z, Mestecky J: Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998; 14:S51-S55.
33. Nardelli-Haefliger DJ, Wirthner D, Schiller J, Lowy D, Hildesheim A, Ponci F, Grandi P: Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human Papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95:1128-1137.
34. Boomsma CM, Kavelaars A, Eijkemans MJ, Lentjes EG, Fauser BC, Heijnen CJ, Macklon NS: Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod 2009; 24:1427-1435.
35. Casado-Vela J, Rodriguez-Suarez E, Iloro I, Ametzazurra A, Alkorta N, Garcia-Velasco JA, Matorras R, Prieto B, Gonzalez S, Nagore D, Simon L, Elortza F: Comprehensive proteomic analysis of human endometrial fluid aspirate. J Proteome Res 2009;8:4622-4632.
36. Boomsma CM, Kavelaars A, Eijkemans MJ, Fauser BC, Heijnen CJ, Macklon NS: Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril 2010; 94:1764-1768.
37. Keller M, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole A, Cole A, Profy A, Wira C, Hogarty K, Herold B: PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007; 21:467-476.
38. Quayle AJ, Martin Porter E, Nussbaum AA, Wang YM, Brabec C, Yip K-P, Mok SC: Gene expression, immunolocalization and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998;152:1247-1258.
39. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV: Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011; 65:196-211.
40. Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y: Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod 1999; 5:656-661.
41. Fahey JV, Kaushic C, Wira CR: Human uterine epithelial cells: influence of culture conditions and stromal cells on epithelial cell transepithelial cell resistance. In Reproductive Immunology, SK Gupta (ed). New Delhi, Narosa Publishing House, 1999, pp 366-378.
42. Wira CR, Stern J: Endocrine regulation of the mucosal immune system in the female reproductive tract: control of IgA, IgG, and secretory component during the reproductive cycle, at implantation and throughout pregnancy. In Hormones and Fetal Pathophysiology. JR Pasqualini, R Scholler (eds). New York, Marcel Dekker Inc, 1992, pp 343-368.
43. Grant KS, Wira CR: Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol Reprod 2003; 69:1091-1098.
44. Godfrey RWA: Human airway epithelial tight junctions. Microsc Res Tech 1997; 38:488-499.
45. Matter K, Aijaz S, Tsapara A, Balda MS: Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005; 17:453-458.
46. Mo B, Vendrov AE, Palomino WA, DuPont BR, Apparao KB, Lessey BA: ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium. Biol Reprod 2006; 75:387-394.
47. Planchon S, Fiocchi C, Takafuji V, Roche JK: Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates and cytokine antagonists. J Cell Physiol 1999; 181:55-66.
48. Shin K, Fogg VC, Margolis B: Tight junctions and cell polarity. Annu Rev Cell Dev Biol 2006; 22:207-235.
49. Simons K, Wandinger-Ness A: Polarized sorting in epithelia. Cell 1990; 62:207-210.
50. Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2:285-293.
51. Grant-Tschudy KS, Wira CR: Effect of estradiol on mouse uterine epithelial cell transepithelial resistance (TER). Am J Reprod Immunol 2004; 52:252-262.
52. Phillips ML, Schultz BD: Steroids modulate transepithelial resistance and Na+ absortion across cultured porcine vas deferens epithelia. Biol Reprod 2002; 66:1016-1023.
53. Groten T, Pierce AA, Huen AC, Schnaper HW: 17 beta-estradiol transiently disrupts adherens junctions in endothelial cells. FASEB J 2005;19:1368-1370.
54. Gorodeski GI: Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology 2007; 148:218-231.
55. Gorodeski GI: Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women. Menopause 2007; 14:1012-1019.
56. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR: Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112:428-436.
57. Schaefer TM, Wright JA, Pioli PA, Wira CR: IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type 1 in uterine epithelial cells. J Immunol 2005; 175:6509-6516.
58. Schust DJ, Ibana JA, Buckner LR, Ficarra M, Sugimoto J, Amedee AM, Quayle AJ: Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection. Curr HIV Res 2012; 10:218-227.
59. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C: Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010; 6:e1000852.
60. Ochiel DO, Fahey JV, Ghosh M, Haddad SN, Wira CR: Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens. Curr Womens Health Rev 2008; 4:102-117.
61. King AE, Critchley HO, Kelly RW: Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod 2000; 6:191-196.
62. King AE, Fleming DC, Critchley HO, Kelly RW: Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol 2003; 59:1-16.
63. Schaefer TM, Fahey JV, Wright JA, Wira CR: Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 2005; 174:992-1002.
64. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T: Human b-defensin-1, an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101:1633-1642.
65. Duits LA, Nibbering PH, van Strijen E, Vos JB, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS: Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol 2003; 38:59-64.
66. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3:710-720.
67. Hocini H, Becquart P, Bouhlal H, Adle-Biassette H, Kazatchkine MD, Belec L: Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol 2000; 7:515-518.
68. Porter E, Yang H, Yavagal S, Preza GC, Murillo O, Lima H, Greene S, Mahoozi L, Klein-Patel M, Diamond G, Gulati S, Ganz T, Rice PA, Quayle AJ: Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005; 73:4823-4833.
69. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A: Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003; 17:F39-F48.
70. Tomee JF, Hiemstra PS, Heinzel-Wieland R, Kauffman HF: Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 1997; 176:740-747.
71. Wahl S, McNeely T, Janoff E, Shugars D, Worley P, Tucker C, Orenstein J: Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis 1997; 3(Suppl 1):S64-S69.
72. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382:829-833.
73. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270:1811-1815.
74. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR: Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2010; 129:207-219.
75. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR: CCL20/MIP3 alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009; 62:60-71.
76. Drannik AG, Nag K, Yao XD, Henrick BM, Ball TB, Plummer FA, Wachihi C, Kimani J, Rosenthal KL: Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells. PLoS One 2012; 7:e52738.
77. Fahey JV, Wira CR: Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185:1606-1613.
78. Beagley KW, Gockel CM: Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38:13-22.
79. Kanda N, Watanabe S: 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol 2003; 120:1058-1066.
80. Kanda N, Watanabe S: 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol 2003; 120:420-427.
81. Kanda N, Watanabe S: 17beta-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes. J Invest Dermatol 2003; 120:411-419.
82. Grant-Tschudy KS, Wira CR: Effect of oestradiol on mouse uterine epithelial cell tumour necrosis factor-alpha release is mediated through uterine stromal cells. Immunology 2005; 115:99-107.
83. Greene CM, McElvaney NG, O'Neill SJ, Taggart CC: Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells. Infect Immun 2004; 72:3684-3687.
84. Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA: Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 1999; 154:239-247.
85. Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ: Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 1999; 117:953-961.
86. Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T: Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 2003; 197:669-674.
87. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG: Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005; 202:1659-1668.
88. Ward PA, Lentsch AB: Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 2002; 234:225-228.
89. Jorgenson RL, Young SL, Lesmeister MJ, Lyddon TD, Misfeldt ML: Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. Hum Immunol 2005; 66:469-482.
90. Lesmeister MJ, Jorgenson RL, Young SL, Misfeldt ML: 17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells. Reprod Biol Endocrinol 2005; 3:74.
91. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, Bennett WA: Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181:915-920.
92. Grosskinsky CM, Halme J: Endometriosis: the host response. Baillieres Clin Obstet Gynaecol 1993; 7:701-713.
93. Pendergrass PB, Belovicz MW, Reeves CA: Surface area of the human vagina as measured from vinyl polysiloxane casts. Gynecol Obstet Invest 2003; 55:110-113.
94. Barnhart KT, Izquierdo A, Pretorius ES, Shera DM, Shabbout M, Shaunik A: Baseline dimensions of the human vagina. Hum Reprod 2006; 21:1618-1622.
95. Farage M, Maibach H: Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 2006; 273:195-202.
96. Herbst-Kralovetz MM, Quayle AJ, Ficarra M, Greene S, Rose WA, Chesson R, Spagnuolo RA, Pyles RB: Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol 2008; 59:212-224.
97. Steele C, Fidel PL: Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002; 70:577-583.
98. Patel MV, Fahey JV, Rossoll RM, Wira CR: Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol 2013; 69:463-474.
99. Scapini P, Laudanna C, Pinardi C, Allavena P, Mantovani A, Sozzani S, Cassatella M: Neutrophils produce biologically active macrophage inflammatory protein-3a (MIP-3a)/CCL20 and MIP-3b/CCL19. Eur J Immunol 2001; 31:1981-1988.
100. Lahey T, Ghosh M, Fahey JV, Shen Z, Mukura LR, Song Y, Cu-Uvin S, Mayer KH, Wright PF, Kappes JC, Ochsenbauer C, Wira CR: Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. PLoS One 2012; 7:e38100.
101. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR: Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 2010; 5:e11366.
102. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, Cunha GR: Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 1997; 94:6535-6540.
103. Lail-Trecker M, Gulati R, Peluso JJ: A role for hepatocyte growth factor/scatter factor in regulating normal and neoplastic cells of reproductive tissues. J Soc Gynecol Investig 1998; 5:114-121.
104. Kankuri E, Cholujova D, Comajova M, Vaheri A, Bizik J: Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res 2005; 65:9914-9922.
105. Skibinski G, Elborn JS, Ennis M: Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am J Physiol Lung Cell Mol Physiol 2007; 293:L69-L76.
106. Conway K, Price P, Harding KG, Jiang WG: The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen 2006; 14:2-10.
107. Grotegut S, von Schweinitz D, Christofori G, Lehembre F: Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25:3534-3545.
108. Morishita R, Aoki M, Hashiya N, Yamasaki K, Kurinami H, Shimizu S, Makino H, Takesya Y, Azuma J, Ogihara T: Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 2004; 4:199-206.
109. Birchmeier C, Gherardi E: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8:404-410.
110. Zhang YW, Vande Woude GF: HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 2003; 88:408-417.
111. Sugawara J, Fukaya T, Murakami T, Yoshida H, Yajima A: Hepatocyte growth factor stimulated proliferation, migration, and lumen formation of human endometrial epithelial cells in vitro. Biol Reprod 1997; 57:936-942.
112. Coleman KD, Wright JA, Ghosh M, Wira CR, Fahey JV: Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil Steril 2009; 92:1107-1109.
113. Grant-Tschudy KS, Wira CR: Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance and tumor necrosis factor alpha release in culture. Biol Reprod 2004; 72:814-821.
114. Grant-Tschudy KS, Wira CR: Paracrine mediators of mouse uterine epithelial cell transepithelial resistance in culture. J Reprod Immunol 2005; 67:1-12.
115. Pioli PA, Weaver LK, Schaefer TM, Wright JA, Wira CR, Guyre PM: Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2. J Immunol 2006; 176:6647-6655.
116. Rodriguez-Garcia M, Biswas N, Patel MV, Barr FD, Crist SG, Ochsenbauer C, Fahey JV, Wira CR: Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One 2013; 8:e62069.
117. Reichelderfer PS, Coombs RW, Wright DJ, Cohn J, Burns DN, Cu-Uvin S, Baron PA, Coheng MH, Landay AL, Beckner SK, Lewis SR, Kovacs AA: Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS 2000; 14:2101-2107.
118. Benki S, Mostad SB, Richardson BA, Mandaliya K, Kreiss JK, Overbaugh J: Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge. J Acquir Immune Defic Syndr 2008;47:529-534.
119. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC: Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 2012; 86:2715-2728.
120. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575-585.
121. Granelli-Piperno A, Pritsker A, Pack M, Shimeliovich I, Arrighi JF, Park CG, Trumpfheller C, Piguet V, Moran TM, Steinman RM: Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J Immunol 2005; 175:4265-4273.
122. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-597.
123. van Kooyk Y, Geijtenbeek TB: DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003; 3:697-709.
124. Miller CJ, McChesney M, Moore PF: Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab Invest 1992; 67:628-634.
125. Miller CJ, Shattock RJ: Target cells in vaginal HIV transmission. Microbes Infect 2003; 5:59-67.
126. Miller CJ: Localization of Simian immunodeficiency virus-infected cells in the genital tract of male and female Rhesus macaques. J Reprod Immunol 1998; 41:331-339.
127. Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, Iwasaki A: Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76:1866-1875.
128. Figdor CG, van Kooyk Y, Adema GJ: C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002; 2:77-84.
129. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW, Cunningham AL: Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 2002; 3:975-983.
130. Wu L, Kewalramani VN: Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 2006; 6:859-868.
131. Ochiel DO, Ochsenbauer C, Kappes JC, Ghosh M, Fahey JV, Wira CR: Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS One 2010; 5:e14306.
132. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
133. King A, Wellings V, Gardner L, Loke YW: Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989; 24:195-205.
134. Sentman CL, Meadows SK, Wira CR, Eriksson M: Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173:6760-6766.
135. Khalil N: Post translational activation of latent transforming growth factor beta (L-TGF-beta): clinical implications. Histol Histopathol 2001; 16:541-551.
136. Eriksson M, Meadows SK, Wira CR, Sentman CL: Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 2004; 76:667-675.
137. Meadows SK, Eriksson M, Barber A, Sentman CL: Human NK cell IFN-gamma production is regulated by endogenous TGF-beta. Int Immunopharmacol 2006; 6:1020-1028.
138. Eriksson M, Meadows SK, Basu S, Mselle TF, Wira CR, Sentman CL: TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol 2006; 176:6219-6224.
139. Eriksson M, Meadows SK, Wira CR, Sentman CL: Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol 2006; 56:321-328.
140. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80:617-653.
141. Smith JM, Shen Z, Wira CR, Fanger MW, Shen L: Effects of menstrual cycle status and gender on human neutrophil phenotype. Am J Reprod Immunol 2007; 58:111-119.
142. Shen L, Fahey JV, Hussey SB, Asin SN, Wira CR, Fanger MW: Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. Cell Immunol 2004; 230:23-32.
143. Schaefer TM, Fahey JV, Wright JA, Wira CR: Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am J Reprod Immunol 2005; 54:193-202.
144. Wira CR, Ghosh M, Smith JM, Shen L, Connor RI, Sundstrom P, Frechette GM, Hill ET, Fahey JV: Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol 2011; 4:335-342.
145. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, Ochiel DO: Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 2010; 63:544-565.